140 likes | 154 Views
Electronic Pharmacovigilance Systems : Drug Safety Surveillance. Z. Mastaneh, Ph.D. Presentation Overview. Pharmaceutical Industry & Pharmacovigilance (PV) Pharmacovigilance (PV) & Information Technologies. Pharmaceutical Industry & Pharmacovigilance (PV). Thalidomide & Phocomelia.
E N D
Electronic PharmacovigilanceSystems: Drug Safety Surveillance Z. Mastaneh, Ph.D
Presentation Overview • Pharmaceutical Industry & Pharmacovigilance (PV) • Pharmacovigilance (PV) & Information Technologies
Pharmaceutical Industry & Pharmacovigilance (PV)
Drug Safety Assessment • Two main phases: • Pre – marketing • Post - marketing Limited Size Narrow Population (age and sex specific) Narrow Indication (only specific disease) Short Duration
Drug Safety Assessment Pharmaceutical Industry & Pharmacovigilance (PV)
Pharmacovigilance (PV) Pharmakon ----- in Greece ------ drug Vigilare ---------- in Latin ------- to keep watch Activities relating to detection, assessment, understanding and prevention of Adverse Drug Reactions (ADRs). (WHO)
Pharmacovigilance (PV) & Information Technology (IT)
International ADR Database Spontaneous Case Reports Case Series Reports National ADR Database Electronic Health Records Data Data from Patient Registries • Case Reviews • Data Mining • … Cohort Studies Results
Prerequisites of National ADR Database • A common reporting form (Electronic form with specific data elements) • Agreed guidelines for data formulating and entering • Common terminologies and classifications • Compatible systems for transmitting, storing, retrieving and disseminating information
Benefits of IT for PV • Safer use of medicines • Quick and timely decision making and taking necessary actions • Reduce costs of ADRs • Observe ethical considerations • Insuring public confidence
Pharmaceutical industry ranking in top 10 profitable industries Furtune Journal, 2010